Abstract
Background: Osteoarthritis (OA) ranks fifth among all forms of disability affecting 10% of the world population. Current treatments available are associated with multiple side effects and do not slow down the progression of the disease. Moreover, no such effective treatment is available to date in various systems of medicine to treat osteoarthritis. Curcumin and Arnica have shown evident clinical advances in the treatment of osteoarthritis.
Objective: The aim of the present study was to design, optimize and characterize novel herbal transdermal patches of curcumin and Arnica montana using factorial design.
Methods: A multiple factorial design was employed to investigate the effect of hydroxypropyl methyl cellulose, ethyl cellulose and jojoba oil on elongation and drug release. Transdermal patches were evaluated by FTIR, DSC, FESEM, ex vivo drug permeation, anti osteoarthritic activity and analgesic activity.
Results: Independent variables exhibited a significant effect on the physicochemical properties of the prepared formulations. The higher values of drug release and elongation were observed with the higher concentration of hydroxypropyl methylcellulose and jojoba oil. Anti osteoarthritic activity was assessed by complete Freund's adjuvant arthritis model; using rats and analgesic activity by Eddy's hot plate method, using mice. Combination patch exhibited good anti osteoarthritic and analgesic activity as compare to individual drug patches.
Conclusion: The design results revealed that the combination patch exhibited good physicochemical, anti osteoarthritic and analgesic activity for the treatment of osteoarthritis in animals. More plants and their combinations should be explored to get reliable, safe and effective formulations that can compete with synthetic drugs.
Keywords: Osteoarthritis, curcumin, Arnica, combination patch, hydroxypropyl, methyl cellulose.
[1]
Mahajan A, Verma S, Tandon V. Osteoarthritis. J Assoc Physicians India 2005; 53: 634-41.
[PMID: 16190135]
[PMID: 16190135]
[2]
Osteoarthritis in India. available from : https: //www.practo.com/ healthfeed/osteoarthritis-in-india-27892/post
[3]
Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: A critical review of the state-of-the-art, current prospects, and future challenges. Bone 2016; 85: 81-90.
[http://dx.doi.org/10.1016/j.bone.2016.01.019] [PMID: 26812612]
[http://dx.doi.org/10.1016/j.bone.2016.01.019] [PMID: 26812612]
[4]
Kivitz A, Fairfax M, Sheldon EA, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther 2008; 30(12): 2366-77.
[http://dx.doi.org/10.1016/j.clinthera.2008.12.015] [PMID: 19167595]
[http://dx.doi.org/10.1016/j.clinthera.2008.12.015] [PMID: 19167595]
[5]
Burch F, Codding C, Patel N, Sheldon E. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial. Osteoarthritis Cartilage 2004; 12(3): 253-5.
[http://dx.doi.org/10.1016/j.joca.2003.10.007] [PMID: 14972343]
[http://dx.doi.org/10.1016/j.joca.2003.10.007] [PMID: 14972343]
[6]
Rathore B, Ali Mahdi A, Nath Paul B, Narayan Saxena P, Kumar Das S. Indian herbal medicines: possible potent therapeutic agents for rheumatoid arthritis. J Clin Biochem Nutr 2007; 41(1): 12-7.
[http://dx.doi.org/10.3164/jcbn.2007002] [PMID: 18392103]
[http://dx.doi.org/10.3164/jcbn.2007002] [PMID: 18392103]
[7]
Park YG, Ha CW, Han CD, et al. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. J Ethnopharmacol 2013; 149(3): 816-24.
[http://dx.doi.org/10.1016/j.jep.2013.08.008] [PMID: 23954277]
[http://dx.doi.org/10.1016/j.jep.2013.08.008] [PMID: 23954277]
[8]
Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of novel drug delivery systems for herbal drugs. Ind J Pharm Edu Res 2011; 45(3): 225-35.
[9]
Rachmawati H, Budiputra DK, Mauludin R. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm 2015; 41(4): 560-6.
[http://dx.doi.org/10.3109/03639045.2014.884127] [PMID: 24502271]
[http://dx.doi.org/10.3109/03639045.2014.884127] [PMID: 24502271]
[10]
Katsuyama Y, Kita T, Horinouchi S, Horinouchi S. Identification and characterization of multiple curcumin synthases from the herb Curcuma longa. FEBS Lett 2009; 583(17): 2799-803.
[http://dx.doi.org/10.1016/j.febslet.2009.07.029] [PMID: 19622354]
[http://dx.doi.org/10.1016/j.febslet.2009.07.029] [PMID: 19622354]
[11]
Mahmood K, Zia KM, Zuber M, Salman M, Anjum MN. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review. Int J Biol Macromol 2015; 81: 877-90.
[http://dx.doi.org/10.1016/j.ijbiomac.2015.09.026] [PMID: 26391597]
[http://dx.doi.org/10.1016/j.ijbiomac.2015.09.026] [PMID: 26391597]
[12]
Dietz V. Homeopathic and Herbal Preparations of Arnica Montana for Treatment of Musculoskeletal Injuries. Integr Med 1998; 1: 42-4.
[13]
Obon C, Rivera D, Verde A, et al. 2012; Arnica: A multivariate analysis of the botany and ethnopharmacology of a medicinal plant complex in the iberian peninsula and the balearic islands. J Ethnopharmacol 2012; 144(1): 44-56.
[http://dx.doi.org/10.1016/j.jep.2012.08.024]
[http://dx.doi.org/10.1016/j.jep.2012.08.024]
[14]
Archer HK, Pettit MS. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery. US patent 5976547. 1997.
[15]
Xie MB, Li Y, Zhao Z, et al. Solubility enhancement of curcumin via supercritical CO2 based silk fibroin carrier. J Supercrit Fluids 2015; 103: 1-9.
[http://dx.doi.org/10.1016/j.supflu.2015.04.021]
[http://dx.doi.org/10.1016/j.supflu.2015.04.021]
[16]
Bilia AR, Bergonzi MC, Mazzi G, Vincieri FF. Development and stability of semisolid preparations based on a supercritical CO2Arnica extract. J Pharm Biomed Anal 2006; 41(2): 449-54.
[http://dx.doi.org/10.1016/j.jpba.2005.12.024] [PMID: 16457981]
[http://dx.doi.org/10.1016/j.jpba.2005.12.024] [PMID: 16457981]
[17]
Wadake DA, Serajuddin ATM, Jacobson H, Liebermann HA, Lachman L, Schwartz JB. The Theory and Practice of Industrial Pharmacy. 2nd ed. NY: Marcel Dekker, Inc. 1989; p. 328.
[18]
Ahmed TA, El-Say KM. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study. Eur J Pharm Sci 2016; 88: 246-56.
[http://dx.doi.org/10.1016/j.ejps.2016.03.015] [PMID: 26993962]
[http://dx.doi.org/10.1016/j.ejps.2016.03.015] [PMID: 26993962]
[20]
Regulation of homeopathy - FDA and HPUS. Available from: http://www.txoptions.com/resources/education/regulation-of-homeopathy/
[21]
Parhi R, Suresh P. Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology. Mater Sci Eng C 2016; 58: 331-41.
[http://dx.doi.org/10.1016/j.msec.2015.08.056] [PMID: 26478318]
[http://dx.doi.org/10.1016/j.msec.2015.08.056] [PMID: 26478318]
[22]
Suksaeree J, Charoenchai L, Madaka F, et al. Zingiber cassumunar Blended patches for skin application: formulation, physicochemical properties, and in vitro studies. Asian J Pharm Sci 2015; 10: 341-9.
[23]
Mamatha T, Venkateswara Rao J, Mukkanti K, Ramesh G. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization. Daru 2010; 18(1): 9-16.
[PMID: 22615587]
[PMID: 22615587]
[24]
Munoz MD, Castan H, Ruiz MA, Morales ME. Design, development and characterization of transdermal patch of methadone. J Drug Deliv Sci Technol in press
[25]
Rajesh N, Siddaramaiah H, Gowda DV, et al. Formulation and evaluation of biopolymer based transdermal drug delivery. Int J Pharm Pharm Sci 2010; 2: 142-7.
[26]
Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm 2011; 2011651909
[http://dx.doi.org/10.5402/2011/651909] [PMID: 22389856]
[http://dx.doi.org/10.5402/2011/651909] [PMID: 22389856]
[27]
Wahid A, Sridhar BK, Shivakumar S. Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan. Indian J Pharm Sci 2008; 70(4): 455-60.
[http://dx.doi.org/10.4103/0250-474X.44593] [PMID: 20046770]
[http://dx.doi.org/10.4103/0250-474X.44593] [PMID: 20046770]
[28]
Ah YC, Choi JK, Choi YK, Ki HM, Bae JH. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 2010; 385(1-2): 12-9.
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.013] [PMID: 19833177]
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.013] [PMID: 19833177]
[29]
Xi H, Cun D, Xiang R, et al. Intra-articular drug delivery from an optimized topical patch containing teriflunomide and lornoxicam for rheumatoid arthritis treatment: does the topical patch really enhance a local treatment? J Control Release 2013; 169(1-2): 73-81.
[http://dx.doi.org/10.1016/j.jconrel.2013.03.028] [PMID: 23567043]
[http://dx.doi.org/10.1016/j.jconrel.2013.03.028] [PMID: 23567043]
[30]
Brind L, Misra A, Srivastava S. Evaluation of central nervous system stimulating and analgesic activities of murraya koenigii leaves. J Acute Med 2014; 4: 81-5.
[http://dx.doi.org/10.1016/j.jacme.2014.03.001]
[http://dx.doi.org/10.1016/j.jacme.2014.03.001]
[31]
Kriplani Priyanka, Guarve Kumar, Baghel Uttam S. Optimization and characterization of transdermal film of curcumin containing natural oils as permeation enhancer by response surface methodology. J Innovat Pharm Biol Sci 2018; 5: 1-15.
[32]
Lin SY, Lee CJ, Lin YY. Drug-polymer interaction affecting the mechanical properties, adhesion strength and release kinetics of piroxicam-loaded eudragit E films plasticized with different plasticizers. J Control Release 1995; 33: 375-81.
[http://dx.doi.org/10.1016/0168-3659(94)00109-8]
[http://dx.doi.org/10.1016/0168-3659(94)00109-8]
[33]
Pichayakorn W, Suksaeree J, Boonme P, Amnuaikit T, Taweepreda W, Ritthidej GC. Deproteinized natural rubber film forming polymeric solutions for nicotine transdermal delivery. Pharm Dev Technol 2013; 18(5): 1111-21.
[http://dx.doi.org/10.3109/10837450.2012.705297] [PMID: 22881292]
[http://dx.doi.org/10.3109/10837450.2012.705297] [PMID: 22881292]
[34]
Frohoff-Hülsmann MA, Schmitz A, Lippold BC. Aqueous ethyl cellulose dispersions containing plasticizers of different water solubility and hydroxypropyl methylcellulose as coating material for diffusion pellets. I. Drug release rates from coated pellets. Int J Pharm 1999; 177(1): 69-82.
[http://dx.doi.org/10.1016/S0378-5173(98)00327-5] [PMID: 10205604]
[http://dx.doi.org/10.1016/S0378-5173(98)00327-5] [PMID: 10205604]
[35]
Anand O, Yu LX, Conner DP, Davit BM. Dissolution testing for generic drugs: an FDA perspective. AAPS J 2011; 13(3): 328-35.
[http://dx.doi.org/10.1208/s12248-011-9272-y] [PMID: 21479700]
[http://dx.doi.org/10.1208/s12248-011-9272-y] [PMID: 21479700]
[36]
Jagtap YM, Bhujbal RK, Ranade AN, Ranpise NS. Effect of various polymers concentrations on physicochemical properties of floating microspheres. Indian J Pharm Sci 2012; 74(6): 512-20.
[http://dx.doi.org/10.4103/0250-474X.110578] [PMID: 23798776]
[http://dx.doi.org/10.4103/0250-474X.110578] [PMID: 23798776]
[37]
Kibria G, Roni MA, Absar MS, Jalil RU. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS PharmSciTech 2008; 9(4): 1240-6.
[http://dx.doi.org/10.1208/s12249-008-9163-4] [PMID: 19101805]
[http://dx.doi.org/10.1208/s12249-008-9163-4] [PMID: 19101805]
[38]
Wagner S, Merfort I. Skin penetration behaviour of sesquiterpene lactones from different Arnica preparations using a validated GC-MSD method. J Pharm Biomed Anal 2007; 43(1): 32-8.
[http://dx.doi.org/10.1016/j.jpba.2006.06.008] [PMID: 16930911]
[http://dx.doi.org/10.1016/j.jpba.2006.06.008] [PMID: 16930911]
[39]
Brinkhaus B, Wilkens JM, Lüdtke R, Hunger J, Witt CM, Willich SN. Homeopathic arnica therapy in patients receiving knee surgery: results of three randomised double-blind trials. Complement Ther Med 2006; 14(4): 237-46.
[http://dx.doi.org/10.1016/j.ctim.2006.04.004] [PMID: 17105693]
[http://dx.doi.org/10.1016/j.ctim.2006.04.004] [PMID: 17105693]
[40]
Hollenbeck KG, Swarbrick J, Boylan JC. Encyclopedia of pharmaceutical technology. 3rd ed. New York: Marcel Dekker 1995; p. 14.
[41]
Khan MZ, Stedul HP, Kurjaković N. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm 2000; 26(5): 549-54.
[http://dx.doi.org/10.1081/DDC-100101266] [PMID: 10789067]
[http://dx.doi.org/10.1081/DDC-100101266] [PMID: 10789067]
[42]
El-Say KM, Ahmed OAA, Aljaeid BM, Zidan AS. Matrix-type transdermal films to enhance simvastatin ex vivo skin permeability. Pharm Dev Technol 2017; 22(4): 492-9.
[http://dx.doi.org/10.3109/10837450.2015.1102279] [PMID: 26512747]
[http://dx.doi.org/10.3109/10837450.2015.1102279] [PMID: 26512747]
[43]
El-Say KM, Ahmed TA, Badr-Eldin SM, Fahmy U, Aldawsari H, Ahmed OAA. Enhanced permeation parameters of optimized nanostructured simvastatin transdermal films: ex vivo and in vivo evaluation. Pharm Dev Technol 2015; 20(8): 919-26.
[http://dx.doi.org/10.3109/10837450.2014.938859] [PMID: 25019166]
[http://dx.doi.org/10.3109/10837450.2014.938859] [PMID: 25019166]
[44]
Elshafeey AH, Hamza YE, Amin SY, Zia H. In vitro transdermal permeation of fenoterol hydrobromide. J Adv Res 2012; 3: 125-32.
[http://dx.doi.org/10.1016/j.jare.2011.05.009]
[http://dx.doi.org/10.1016/j.jare.2011.05.009]
[45]
Liu W, Li Y, Yue Y, et al. Synthesis and biological evaluation of curcumin derivatives containing NSAIDs for their anti-inflammatory activity. Bioorg Med Chem Lett 2015; 25(15): 3044-51.
[http://dx.doi.org/10.1016/j.bmcl.2015.04.077] [PMID: 26048786]
[http://dx.doi.org/10.1016/j.bmcl.2015.04.077] [PMID: 26048786]
[46]
Huber R, Bross F, Schempp C, Gründemann C. Arnica and stinging nettle for treating burns - a self-experiment. Complement Ther Med 2011; 19(5): 276-80.
[http://dx.doi.org/10.1016/j.ctim.2011.08.001] [PMID: 21944657]
[http://dx.doi.org/10.1016/j.ctim.2011.08.001] [PMID: 21944657]
Article Metrics
50
3
1
